Facebook
Twitter
LinkedIn
ForwardMayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practices - LIVE
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Directors: Halena M. Gazelka, M.D. , Benjamin Lai, M.B., B.Ch., B.A.O. and Julie L. Cunningham, Pharm.D., R.Ph.
September 29 - October 1, 2022 - The Ritz-Carlton, Rancho Mirage - Rancho Mirage, California
The Mayo Clinic Opioid Conference: Evidence, Clinical Considerations & Best Practice 2022 aims to highlight the shift in guidelines and public concern regarding the use of opioids in medical practice. This course provides the most up-to-date information regarding the appropriate indication for opioids in clinical practice. Topics cover the basics of opioid pharmacology and selection, evidence-based guidelines for opioid management, opioid tapering and legal considerations, as well as medical and interventional alternatives to opioids. In addition, the course covers a broad range of issues, including opioid use disorder and difficult patient conversations and guidelines to standardize the practice of opioid prescribing. This course includes lectures by experts in the field of pain medicine and opioid management as well as question and answer sessions.
Course Highlights:
- Learn the most up-to-date information regarding the appropriate use and management of opioids in clinical practice.
- Discuss the basics of opioid pharmacology, selection, and side effect management, along with evidence-based guidelines for opioid
- management, tapering, and legal considerations, and medical and interventional alternatives to opioids.
- Address opioid use disorder, difficult patient conversations and guidelines to standardize the practice of opioid prescribing
LIVE (in-person) attendees must comply with all live course requirements and guidelines and applicable state and local COVID-19 travel restrictions, guidance and resources.
Please note that all live course attendees must:
- Complete COVID-19 testing of any kind and provide attestation that a negative test result was received within 72 hours or less of the event start date or provide attestation that you received any positive COVID-19 test result within the previous 90 days, that it has been at least 10 days since COVID-19 infection, and that you are currently asymptomatic.
- Attest that you will comply with all safety requirements and that you understand the inherent risk associated with being in large groups of people.
- Complete your attestation here.
Attendees who are not able to complete the above attestations are unable to attend the live (in-person) event.
Requirements and guidelines may be amended as CDC, public health and other relevant guidance are adjusted.
Target Audience
This topic is important and has become a more visible public health issue. All fields within medicine that provide direct patient care are impacted, including medical, surgical and outpatient settings. All providers who prescribe (MD, DO, NP, PA, CNS) or administer (nurse, pharmacist, etc.) opioids to patients would benefit from attending this course. This course is particularly relevant for primary care providers that maintain and monitor patients on chronic opioid therapy.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Review opioid practice updates and discuss how to implement a plan to appropriately monitor patients who chronically use opioids.
- Define methods to taper opioids using a team-based approach and the options for proper opioid disposal.
- Describe the use of methadone and buprenorphine in the management of chronic pain.
- Determine and optimize treatment for patients suffering from pain and comorbid depression/anxiety.
- Identify those with opioid use disorder and understand medications for opioid use disorder (MOUD).
- Explain how to apply best practice for non-opioid adjuvants, interventional pain therapies, and alternative pain modalities as part of a comprehensive multimodal pain management plan.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
All travel and lodging expenses are the sole responsibility of the individual registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA
Mayo Clinic College of Medicine and Science designates this other activity (live and livestream) for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
| Day | Credit |
|---|---|
| Thursday | 4.75 |
| Thursday (Optional Pre-Course) | 2.00 |
| Friday | 4.50 |
| Saturday | 4.50 |
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 13.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
ACPE
Mayo Clinic College of Medicine and Science designates this educational activity for a maximum of 13.75 knowledge-based contact hours. Participants should only claim credit commensurate with the extent of their participation in the activity.
Universal Activity Number (UAN): JA0000238-0000-22-033-L01-P
AAFP
The AAFP has reviewed Mayo Clinic Opioid Conference: Evidence, Clinical Considerations, and Best Practice 2022 and deemed it acceptable for up to 15.75 Live AAFP Prescribed credits. Term of Approval is from 09/29/2022 to 10/01/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 13.75 AAFP Prescribed
- 13.75 ACPE
- 13.75 AMA PRA Category 1 Credit™
- 13.75 ANCC
- 13.75 Attendance
Price
LIVE (in-person) attendees must comply with all live course requirements and guidelines and applicable state and local COVID-19 travel restrictions, guidance and resources.
Please note that all live course attendees must:
- Complete COVID-19 testing of any kind and provide attestation that a negative test result was received within 72 hours or less of the event start date or provide attestation that you received any positive COVID-19 test result within the previous 90 days, that it has been at least 10 days since COVID-19 infection, and that you are currently asymptomatic.
- Attest that you will comply with all safety requirements and that you understand the inherent risk associated with being in large groups of people.
- Complete your attestation here.
Attendees who are not able to complete the above attestations are unable to attend the live (in-person) event.
Requirements and guidelines may be amended as CDC, public health and other relevant guidance are adjusted.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.